| Biomarker ID | 1205 |
| PMID | 23984644 |
| Year | 2013 |
| Biomarker | hsa-mir-33a; hsa-mir-25; hsa-mir-18b; hsa-mir-130b; hsa-mir-769; hsa-mir-182; hsa-mir-148a; hsa-mir-96; |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in PCa (log Fold Change): [] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Cancer Vs Benign |
| Type of Biomarker | Diagnostic |
| Cohort | The accession number of expression profile is GSE36802, containing 21 paired samples from prostate cancer tissue and benign prostate tissue. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p < 0.0401 |
| Method Used | Affymetrix miRNA Array |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | hsa-mir-33a, hsa-mir-25, hsa-mir-18b, hsa-mir-130b, hsa-mir-769, hsa-mir-182, hsa-mir-148a, hsa-mir-96 |